Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.
Pfizer Inc. v. Teva Pharmaceuticals Usa, Inc.
Opinion
Case: 12-1576 Document: 70 Page: 1 Filed: 10/17/2012
NOTE: This order is nonprecedential.
mtntteb ~tates <!Court of ~peaIs for tbe jfeberaI <!Ctreutt
PFIZER INC., WARNER-LAMBERT COMPANYLLC, AND C.P. PHARMACEUTICALS INTERNATIONAL C.V., Plaintiffs-Appellees,
AND NORTHWESTERN UNIVERSITY, Plaintiff-Appellee,
v. TEVA PHARMACEUTICALS USA, INC. AND TEVA PHARMACEUTICAL INDUSTRIES, LTD., Defendants-Appellants,
AND LUPIN, LTD. AND LUPIN PHARMACEUTICALS, INC., Defendants-Appellants,
AND
ACTAVIS, INC. AND ACTAVIS ELIZABETH, LLC, Defendants-Appellants,
AND COBALT LABORATORIES, INC. AND COBALT PHARMACEUTICALS, INC., Defendants-Appellants, Case: 12-1576 Document: 70 Page: 2 Filed: 10/17/2012
PFIZER INC. V. TEVA PHARMACEUTICALS USA 2
AND
SUN PHARMA GLOBAL, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., AND SUN PHARMACEUTICAL INDUSTRIES, INC., Defendants-Appellants,
AND
WOCKHARDT LIMITED AND WOCKHARDT USA, LLC, Defendants-Appellants,
AND
ALPHAPHARM PTY. LTD. AND MYLAN PHARMACEUTICALS, INC., Defendants-Appellants.
2012-1576, -1601, -1602, -1603, -1604, -1605, -1607
Appeals from the United States District Court for the District of Delaware in consolidated case no. 09-CV-0307, Chief Judge Gregory M. Sleet.
ON MOTION
ORDER The parties jointly move for an extension of 31 days, until November 19, 2012, for the appellants to file their principal briefs and 46 days, until February 15, 2013, for appellees to file their responsive brief. Case: 12-1576 Document: 70 Page: 3 Filed: 10/17/2012
PFIZER INC. V. TEVA PHARMACEUTICALS USA 3
Upon consideration thereof,
IT Is ORDERED THAT:
The motion is granted.
FOR THE COURT
/s/ Jan Horbaly Jan Horbaly Clerk s27
Reference
- Status
- Unpublished